Evotec SE (EVO) Asset Utilization Ratio (2009 - 2025)

Evotec SE (EVO) reported Asset Utilization Ratio of 0.89 for Q4 2025, up 76472802.19% on a YoY basis from N/an in Q4 2024, and up 46.48% sequentially from 0.61 in Q3 2025.

Evotec SE (EVO) Asset Utilization Ratio (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 7 years of Asset Utilization Ratio data on file, last reported at 0.89 in Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 76472802.19% year-over-year to 0.89; the trailing twelve-month figure through Dec 2025 stood at 0.89 (up 76472802.19% YoY), and the FY2025 full-year result was 0.9, up 110044304.14% from the prior year.
  • Asset Utilization Ratio climbed to 0.89 in Q4 2025, from 0.61 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.89 in Q4 2025 to a low of 0.0 in Q1 2022.
  • A 4-year average of 0.26 and a median of 0.02 in 2024 frame the typical range for Asset Utilization Ratio.
  • Across the five-year window, Asset Utilization Ratio jumped 3846546.17% in 2022 and jumped 76472802.19% in 2025, its largest moves.
  • Tracing EVO's Asset Utilization Ratio over 4 years: stood at 0.0 in 2021, then soared by 3846546.17% to 0.04 in 2022, then sank by 100.0% to 0.0 in 2024, then jumped by 76472802.19% to 0.89 in 2025.
  • Business Quant data shows EVO's Asset Utilization Ratio at 0.89 in Q4 2025, 0.61 in Q3 2025, and 0.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 0.43
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 0.62
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 0.46
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 0.43
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 0.39
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 0.65
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 0.37
10 Evotec SE 351.60 Mn 351.08 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.89
Sep 30, 2025 0.61
Dec 31, 2024 0.00
Dec 31, 2022 0.04
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Dec 31, 2019 78.62
Sep 30, 2010 64.59
Jun 30, 2010 142.89
Mar 31, 2010 107,685.03
Jun 30, 2009 48,064.84
Mar 31, 2009 45,656.65